United States:
Senate Advances Emergency Medicine Access Legislation
30 October 2017
Reed Smith
To print this article, all you need is to be registered or login on Mondaq.com.
On October 24, 2017, the Senate approved HR 304, the Protecting Patient Access to
Emergency Medicines Act, which would clarify that emergency medical
services professionals may administer controlled substances
pursuant to standing or verbal orders in certain circumstances.
While the House passed the legislation in January 2017, the House
needs to consider the measure again due to amendments adopted in
the Senate.
This article is presented for informational purposes only
and is not intended to constitute legal advice.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...
